Since our study developed prediction models using TLR4 and TLR9 gene polymorphisms for remission of RA in patients taking TNF-α inhibitors, result of this study could be utilized to develop and design individually tailored TNF-α inhibitor treatments for RA patients. Here, TNF is linked to rheumatoid arthritis.